BIOS Capital Management as of June 30, 2026
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 36.9 | $15M | 10M | 1.53 | |
| Ocuphire Pharma (IRD) | 36.3 | $15M | 3.7M | 4.11 | |
| Cognition Therapeutics (CGTX) | 16.6 | $6.9M | 6.0M | 1.15 | |
| Rein Therapeutics Com New (RNTX) | 7.4 | $3.1M | 3.0M | 1.04 | |
| Lantern Pharma (LTRN) | 2.5 | $1.0M | 249k | 4.17 | |
| In8bio Com New (INAB) | 0.3 | $114k | 81k | 1.41 |
